Related Experiment Videos
Cellular processing and proteoglycan nature of amyloid precursor proteins
N K Robakis1, D Vassilacopoulou, S Efthimiopoulos
1Department of Psychiatry and Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York, New York 10029.
Annals of the New York Academy of Sciences
|September 24, 1993
Summary
Amyloid precursor protein (APP) is processed into amyloid beta, a key component of Alzheimer's disease. Recent findings suggest APP's proteoglycan nature is crucial for its biological function.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alzheimer's disease is characterized by amyloid beta (A beta) protein depositions.
- Amyloid precursor protein (APP) is the source of A beta through proteolytic processing.
- The biological function of APP is not fully understood, but it may act as a cell adhesion molecule.
Purpose of the Study:
- To investigate the biological function of APP.
- To explore the role of APP's proteoglycan nature in its function.
Main Methods:
- Analysis of APP processing and cleavage sites.
- Detection of soluble secreted APP and full-length APP in various cell types and human brain tissue.
- Characterization of APP as a chondroitin sulfate proteoglycan (CSPG).
Main Results:
- APP undergoes distinct secretase cleavages, producing soluble secreted APP.
- Soluble secreted APP and full-length APP exist as chondroitin sulfate proteoglycans (CSPGs) in glioma, neuroblastoma, and fibroblast cells.
- APP CSPG is also found on glioma cell surfaces and in the human brain.
Conclusions:
- The proteoglycan nature of APP, specifically as CSPG, may be essential for its biological activity.
- Further research into APP CSPG is warranted to elucidate its role in cellular function and potential implications in neurological disorders like Alzheimer's disease.